Extramural Funding
NSF Convergence Accelerator Phase I and II
Preliminary Proposal Due Date: May 11, 2020, 5:00pm local time
Full Proposal Deadline(s): Phase I: July 10, 2020, 5:00pm | Phase II: May 17, 2021, 5:00pm
Anticipated Funding Amount: $30,000,000
The goals of NSF’s convergence accelerator effort are to support and accelerate use-inspired
convergence research in areas of national importance within particular topics (tracks).
NSF Convergence Accelerator tracks can be related to Industries of the Future (IotF), NSF’s Big Ideas, or other topics, that may not relate directly to an IotF or Big Idea, however, they must have the potential for significant national impact.
The 2020 NSF Convergence Accelerator is a two-phase program. Both phases are described
in this solicitation. Phase I awardees receive significant resources to further develop
their convergence research ideas and identify crucial partnerships and resources to
accelerate their projects, leading to deliverable research prototypes in Phase II.
This solicitation invites proposals for the following Tracks: Quantum Technology (Track C)
AI-Driven Innovation via Data and Model Sharing (Track D)
The NSF Convergence Accelerator leverages fundamental research leading to rapid advances
that can deliver significant societal impact. Proposers must first submit a Phase
i preliminary proposal in order to be invited to submit a full Phase I proposal. The information
required in the preliminary proposal is described in section V.
Phase I proposals must describe a team, or a process to build a team, that includes
personnel with the appropriate mix of disciplinary and institutional expertise needed
to build a Phase II convergence research effort. Phase I proposals must describe one
or more deliverables and how those research outputs could impact society by the end
of Phase II. Phase I proposals should describe the deliverable and the research plan
and team formation efforts that will refine it to a proof-of-concept. Phase I will
include NSF-organized convenings for training and intra- and cross-cohort collaboration.
Phase I awards are expected to be for up to 9 months and up to $1M each.
Only awardees of Phase I grants under this solicitation may submit a Phase II proposal.
Phase II proposers must outline a two-year research and development plan in which
research transitions to practice through collaboration with end-users.
Phase II proposals must describe clear deliverables that will be produced in two years
of effort and the metrics by which impacts will be assessed. The Phase II teams must
include appropriate stakeholders (e.g., industry, Institutions of Higher Education
(IHEs), non- profits, government entities, and others), each with a specific role(s)
in facilitating the transition of research outputs into practical uses. Successful
proposals will be funded initially for one year. Each team’s progress will be assessed
during the year through approximately six virtual and in-person meetings with NSF
program staff. The overall progress will be evaluated at the end of one year, based
on a report and presentation that the team will make to a panel of reviewers. Teams
that show significant progress during the first year, in accordance with the agreed
timetable of milestones and deliverables, will receive funding for a second year.
Teams should plan on completing the effort within two years; no-cost extensions will
be authorized only in extraordinary circumstances.
Please contact the NSF Program Officers below with any questions:
Linda Molnar, telephone: (703) 292-8316
Lara A. Campbell, telephone: (703) 292-7049
Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA)
Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need
Notice Number: NOT-TR-20-011
First Available Due Date: May 04, 2020
Expiration Date: July 10, 20210
Purpose
National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for
research on the 2019 novel Coronavirus (COVID-19). NCATS is particularly interested
in projects focusing on the use of informatics solutions to diagnose cases and the
use of CTSA-supported core resources (e.g., advanced scientific instruments, highly-specialized
facilities, and regulatory expertise) to facilitate research on COVID-19 and advance
the translation of research findings into diagnostics, therapeutics, and vaccines.
NCATS is soliciting applications for Administrative Supplements to UL1, U01, and R21
awards (through PA-18-591), Collaborative Innovation Awards to U01 and R21 awards (through PAR-19-099 and PAR-19-100, respectively), and Competitive Revisions for UL1 awards for each of the non-administrative
supplement awards (through PAR-19-337).
Categories
Featured Posts
Blog Archive
- September 2018 (1)
- April 2019 (26)
- August 2019 (17)
- December 2019 (10)
- February 2019 (25)
- July 2019 (14)
- June 2019 (16)
- March 2019 (17)
- May 2019 (13)
- November 2019 (8)
- October 2019 (20)
- September 2019 (14)
- April 2020 (13)
- August 2020 (10)
- December 2020 (11)
- February 2020 (12)
- January 2020 (10)
- July 2020 (9)
- June 2020 (7)
- March 2020 (30)
- May 2020 (10)
- November 2020 (15)
- October 2020 (21)
- September 2020 (19)
- April 2021 (10)
- August 2021 (21)
- December 2021 (12)
- February 2021 (17)
- January 2021 (10)
- July 2021 (11)
- June 2021 (17)
- March 2021 (21)
- May 2021 (14)
- November 2021 (16)
- October 2021 (15)
- September 2021 (16)
- April 2022 (8)
- August 2022 (15)
- December 2022 (11)
- February 2022 (14)
- January 2022 (9)
- July 2022 (14)
- June 2022 (12)
- March 2022 (22)
- May 2022 (14)
- November 2022 (14)
- October 2022 (17)
- September 2022 (18)
- Jan 2023 (15)
Warning: Undefined array key 1 in /var/www/html/_resources/oublog/blog-functions.php on line 123
Tag Cloud
- Language (1)
- translation (1)
- support (1)
- research (2)
- COVID19 (3)
- VPR (2)
- Intramural Funding (1)
- NEXUS (1)
- Aging (2)
- Extramural Funding (1)
- NSF (1)
- Convergence (1)
- CTSA (1)
- Clinical (1)
- Corporate (2)
- foundation (2)
- funding (2)
- Administration (1)
- assessment (1)
- Research (1)
- 3i (1)
- Immunology (1)
- Inflammation (1)
- Infectious (1)
- Newsletter (1)
- Limited Submissions (1)
- Funding (3)
- Pew (1)
- Biomedical (1)
- Searle (1)
- Diabetes (1)
- Grant (1)
- SIA (1)
- Mallinckrodt (1)
- Intramural (1)
- COA (1)
- Extramural (1)
- COVID (1)
- Clinical Trials (1)
- PPE (1)
- EHS (1)
- Safety (1)